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Background: Peripheral Arterial Disease (PAD) is a highly prevalent disease, which is forecast to affect up to 23 million individuals by 2012 
as obesity and the ageing population increase the incidence of cardiovascular disease. Current treatment options are limited, providing only 
symptomatic relief and surgery to restore blood flow to the limb. We have developed a percutaneous recirculation system (V-Vascular, V-V) to enable 
treatment of critical limb ischemia and infected wounds associated with progression of PAD by delivering agents that facilitate vessel dilation, 
angiogenesis, tissue regeneration and healing in the targeted limb. 
Methods: Gentamicin, an easily detected antibiotic, was delivered to the ovine hind limb (4 mg/kg) using the V-V system, a ‘closed’ recirculatory 
catheter system that draws blood from the venous system and returns it to the artery via an oxygenator, or via intra-venous (IV) infusion. Samples of 
muscle, bone and synovial fluid of the limb were collected at 30 and 60 min post administration of gentamicin.
Results: There was a significantly greater concentration of gentamicin observed in the bone and skeletal muscle of limbs receiving the antibiotic 
via V-V at 30 min post administration compared to IV delivery, (bone V-V 0.05 ± 0.04, I.V 0.004 ± 0.001 mg/L p<0.05; muscle V-V 0.005 ± 0.001, 
I.V 0.002 ± 0.0005 mg/L p<0.05) and bone and synovial fluid at 60 min post administration (bone V-V 0.06 ± 0.02, I.V 0.005 ± 0.001 mg/L 
p<0.05; synovial fluid V-V 34.58 ± 14.9, I.V 3.03 ± 0.59 mg/L p<0.05).
Conclusions: These results suggest that the use of percutaneous recirculation is a safe and effective method for delivering a greater concentration 
of agents (in this case antibiotic) to the limb without systemic implications.
